Aptamer-Based Targeted Protein Degradation
ACS Nano · 11.04.2023 · 17 (7) · 6150-6164
DOI: 10.1021/acsnano.2c10379 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Nano, online erschienen am 21.03.2023. Verfasst von Yuan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, Chin…. Hauptthemen laut MEDLINE: Aptamers, Nucleotide. Die Arbeit wurde bisher 115-mal zitiert (Crossref) und nennt 156 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The selective removal of misfolded, aggregated, or aberrantly overexpressed protein plays an essential role in maintaining protein-dominated biological processes. In parallel, the precise knockout of abnormal proteins is inseparable from the accurate identification of proteins within complex environments. Guided by these precepts, small molecules, or antibodies, are commonly used as protein recognition tools for developing targeted protein degradation (TPD) technology. Indeed, TPD has shown tremendous prospects in chronic diseases, rare diseases, cancer research, and other fields. Meanwhile, aptamers are short RNA or DNA oligonucleotides that can bind to target proteins with high specificity and strong affinity. Accordingly, aptamers are actively used in designing and constructing TPD technology. In this perspective, we provide a brief introduction to TPD technology in its current progress, and we summarize its application challenges. Recent advances in aptamer-based TPD technology are reviewed, together with corresponding challenges and outlooks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China.
- School of Molecular Medicine, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China.
- Molecular Science and Biomedicine Laboratory (MBL), State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, College of Biology, Aptamer Engineering Center of Hunan Provi…
- Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Xu Qian, Weihong Tan
Förderung
- Ministry of Science and Technology of the People's Republic of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Qian, X., Ran, C., Li, L., Fu, T., Su, D., Xie, S., & Tan, W. (2023). Aptamer-Based Targeted Protein Degradation. ACS Nano, 17(7), 6150-6164. https://doi.org/10.1021/acsnano.2c10379
Vancouver
Liu Y, Qian X, Ran C, Li L, Fu T, Su D, et al. Aptamer-Based Targeted Protein Degradation. ACS Nano. 2023;17(7):6150-6164. doi:10.1021/acsnano.2c10379
BibTeX
@article{Liu2023,
author = {Liu, Yuan and Qian, Xu and Ran, Chunyan and Li, Longjie and Fu, Ting and Su, Dan and Xie, Sitao and Tan, Weihong},
title = {Aptamer-Based Targeted Protein Degradation},
journal = {ACS Nano},
year = {2023},
volume = {17},
number = {7},
pages = {6150--6164},
doi = {10.1021/acsnano.2c10379}
}
EUVIMED